| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1355617707071214 |
| P698 | PubMed publication ID | 17697407 |
| P50 | author | Jane S. Paulsen | Q47503879 |
| P2093 | author name string | Janice L Zimbelman | |
| Raymond G Hoffmann | |||
| Stephen M Rao | |||
| Ania Mikos | |||
| Norman C Reynolds | |||
| P2860 | cites work | Pathological cell-cell interactions elicited by a neuropathogenic form of mutant Huntingtin contribute to cortical pathogenesis in HD mice. | Q45296827 |
| Brain structure in preclinical Huntington's disease. | Q45298184 | ||
| Longitudinal cognitive and motor changes among presymptomatic Huntington disease gene carriers | Q45298331 | ||
| Regional cortical thinning in preclinical Huntington disease and its relationship to cognition | Q45298420 | ||
| Reduced basal ganglia blood flow and volume in pre-symptomatic, gene-tested persons at-risk for Huntington's disease | Q45298929 | ||
| Preparing for preventive clinical trials: the Predict-HD study | Q45301513 | ||
| Clinical markers of early disease in persons near onset of Huntington's disease. | Q45303704 | ||
| Single photon emission computerized tomography (SPECT) in detecting neurodegeneration in Huntington's disease. | Q45304914 | ||
| The distribution of structural neuropathology in pre-clinical Huntington's disease | Q45306498 | ||
| Temporal processing in the basal ganglia | Q48538251 | ||
| The cerebellum communicates with the basal ganglia | Q48744096 | ||
| Alterations in memory networks in mild cognitive impairment and Alzheimer's disease: an independent component analysis. | Q51978821 | ||
| Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. | Q53350823 | ||
| Unified Huntington's disease rating scale: Reliability and consistency | Q57422462 | ||
| Timing functions of the cerebellum | Q87295787 | ||
| The evolution of brain activation during temporal processing | Q22337261 | ||
| The assessment and analysis of handedness: The Edinburgh inventory | Q26778476 | ||
| A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. | Q27860836 | ||
| Voxel-based morphometry–the methods | Q28138780 | ||
| A voxel-based morphometric study of ageing in 465 normal adult human brains | Q28214553 | ||
| Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease | Q28589793 | ||
| Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules | Q28590634 | ||
| AFNI: software for analysis and visualization of functional magnetic resonance neuroimages | Q29547544 | ||
| Unified segmentation | Q29616050 | ||
| Region-specific changes in prefrontal function with age: a review of PET and fMRI studies on working and episodic memory | Q30996947 | ||
| Age at onset in Huntington's disease: effect of line of inheritance and patient's sex. | Q33597329 | ||
| Patterns of brain activation in people at risk for Alzheimer's disease. | Q33700984 | ||
| Huntington's disease: the challenge for cell biologists | Q34106564 | ||
| Why voxel-based morphometric analysis should be used with great caution when characterizing group differences | Q34342777 | ||
| Aging cognition: from neuromodulation to representation | Q34421919 | ||
| Subtle changes among presymptomatic carriers of the Huntington's disease gene | Q35460244 | ||
| Neuropsychological stability over two years in asymptomatic carriers of the Huntington's disease mutation | Q36900144 | ||
| Familial risk for Alzheimer's disease alters fMRI activation patterns. | Q37348964 | ||
| Evidence for specific cognitive deficits in preclinical Huntington's disease. | Q38452724 | ||
| Distributed neural systems underlying the timing of movements. | Q38557285 | ||
| Onset and rate of striatal atrophy in preclinical Huntington disease | Q40496996 | ||
| The accuracy and precision of timing of self-paced, repetitive movements in subjects with Parkinson's disease | Q40951948 | ||
| Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. | Q45290072 | ||
| A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. | Q45292888 | ||
| Basal ganglia volume and proximity to onset in presymptomatic Huntington disease | Q45293561 | ||
| Functional brain changes in presymptomatic Huntington's disease | Q45293738 | ||
| Central motor processing in Huntington's disease. A PET study | Q45295098 | ||
| Cortical control of movement in Huntington's disease. A PET activation study | Q45295104 | ||
| Critical periods of suicide risk in Huntington's disease | Q45296374 | ||
| P433 | issue | 5 | |
| P921 | main subject | Huntington's disease | Q190564 |
| functional magnetic resonance imaging | Q903809 | ||
| P304 | page(s) | 758-769 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | Journal of the International Neuropsychological Society | Q15755321 |
| P1476 | title | fMRI detection of early neural dysfunction in preclinical Huntington's disease | |
| P478 | volume | 13 |
| Q41518825 | Abnormal cerebellar volume and corticocerebellar dysfunction in early manifest Huntington's disease. |
| Q34917383 | Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease |
| Q45300770 | Abnormal resting-state connectivity of motor and cognitive networks in early manifest Huntington's disease |
| Q35888638 | Altered brain mechanisms of emotion processing in pre-manifest Huntington's disease. |
| Q96136140 | Altered neural substrates within cognitive networks of postpartum women during working memory process and resting-state |
| Q41497318 | Basal ganglia-cortical structural connectivity in Huntington's disease |
| Q33489152 | Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data |
| Q41765226 | Biomarkers to predict and track diseases |
| Q45289548 | Brain activation and functional connectivity in premanifest Huntington's disease during states of intrinsic and phasic alertness |
| Q37227655 | Cognitive decline in prodromal Huntington Disease: implications for clinical trials |
| Q37267442 | Cognitive domains that predict time to diagnosis in prodromal Huntington disease |
| Q36773397 | Cognitive impairment in Huntington disease: diagnosis and treatment |
| Q38430852 | Cognitive interventions to enhance neural compensation in Huntington's disease |
| Q36711087 | Consistent neurodegeneration and its association with clinical progression in Huntington's disease: a coordinate-based meta-analysis |
| Q35048655 | Coordination of fingertip forces during precision grip in premanifest Huntington's disease |
| Q33517189 | Current role of functional MRI in the diagnosis of movement disorders |
| Q34973519 | Default-mode network changes in Huntington's disease: an integrated MRI study of functional connectivity and morphometry |
| Q36303696 | Depressive symptoms in prodromal Huntington's Disease correlate with Stroop-interference related functional connectivity in the ventromedial prefrontal cortex |
| Q30403689 | Disruption of response inhibition circuits in prodromal Huntington disease |
| Q37386063 | Early Detection of Huntington Disease |
| Q37325474 | Elevated arteriolar cerebral blood volume in prodromal Huntington's disease |
| Q30437914 | Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice |
| Q33965402 | Frontal cortex BOLD signal changes in premanifest Huntington disease: a possible fMRI biomarker |
| Q30696281 | Functional changes during working memory in Huntington's disease: 30-month longitudinal data from the IMAGE-HD study. |
| Q34096680 | Functional connectivity of primary motor cortex is dependent on genetic burden in prodromal Huntington disease. |
| Q33403110 | Functional imaging in Huntington's disease |
| Q31139646 | Functional imaging of cognitive processes in Huntington's disease and its presymptomatic mutation carriers |
| Q30659199 | Functional magnetic resonance imaging of working memory in Huntington's disease: cross-sectional data from the IMAGE-HD study. |
| Q44921266 | Impaired postural stability as a marker of premanifest Huntington's disease |
| Q37683775 | Intact sensory-motor network structure and function in far from onset premanifest Huntington's disease |
| Q36021158 | Longitudinal Changes in the Motor Learning-Related Brain Activation Response in Presymptomatic Huntington's Disease |
| Q44250471 | Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6/2 mouse model of Huntington's disease. |
| Q45295163 | Longitudinal task-negative network analyses in preclinical Huntington's disease |
| Q33437923 | Magnetic resonance imaging of Huntington's disease: preparing for clinical trials |
| Q35262146 | Magnetic resonance perfusion imaging of resting-state cerebral blood flow in preclinical Huntington's disease |
| Q39564387 | Magnetization transfer imaging in premanifest and manifest huntington disease: a 2-year follow-up. |
| Q37776087 | Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease |
| Q30407344 | Music perception and movement deterioration in Huntington's disease |
| Q37255302 | Network topology and functional connectivity disturbances precede the onset of Huntington's disease. |
| Q37608603 | Neuroanatomical correlates of cognitive functioning in prodromal Huntington disease |
| Q41850803 | Patients with schizophrenia show aberrant patterns of basal ganglia activation: Evidence from ALE meta-analysis |
| Q36900689 | Plasma 24S-hydroxycholesterol correlation with markers of Huntington disease progression |
| Q33911062 | Postural control in bipolar disorder: increased sway area and decreased dynamical complexity. |
| Q30461090 | R6/2 Huntington's disease mice develop early and progressive abnormal brain metabolism and seizures |
| Q45291055 | Reduction in cerebral atrophy associated with ethyl-eicosapentaenoic acid treatment in patients with Huntington's disease. |
| Q33606063 | Seeking brain biomarkers for preventive therapy in Huntington disease. |
| Q30474980 | Self-paced timing detects and tracks change in prodromal Huntington disease |
| Q60961136 | Short-Term Environmental Stimulation Spatiotemporally Modulates Specific Serotonin Receptor Gene Expression and Behavioral Pharmacology in a Sexually Dimorphic Manner in Huntington's Disease Transgenic Mice |
| Q35663246 | Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease |
| Q45294729 | Temporal order memory deficits prior to clinical diagnosis in Huntington's disease |
| Q90593606 | The Role of Hypothalamic Pathology for Non-Motor Features of Huntington's Disease |
| Q38206500 | The cognitive burden in Huntington's disease: pathology, phenotype, and mechanisms of compensation |
| Q45306798 | The structural correlates of functional deficits in early huntington's disease |
| Q45302831 | The structural involvement of the cingulate cortex in premanifest and early Huntington's disease |
| Q28067588 | Time Processing and Motor Control in Movement Disorders |
Search more.